by Kristina Campbell
Teams of scientists from around the world envisage new solutions and methods for treating and preventing different kinds of allergic diseases, thanks to our gut microbiota and its preventive role.
2025 has been a productive year in gut microbiome research, spanning metabolic health, neurogastroenterology, immune modulation, and precision nutrition. In this ‘Year in Review’ article, the GMFH editing team describes their pick of the top GMFH-covered advances in 2025, outlining their impact in the clinical setting and implications for current and future research.
by Cristina Sáez
A new study reveals that a molecule produced by gut bacteria can trigger atherosclerosis, shedding light on why some healthy individuals develop cardiovascular disease.
by Mónica Quinzo
The definition of a prebiotic has evolved from a focus on colonic fiber to a complex ecological strategy. This article traces the concept's 30-year journey, highlighting the shift from non-digestible carbohydrates to the latest expert recommendations.
Emerging studies suggest the gut microbiome may predict how well you age. The world’s oldest person offers scientists new clues into the secrets of healthy aging and protection against the diseases that often plague the final years of life.
by Andreu Prados
Cardiovascular diseases remain one of the most pressing public health concerns, demanding innovative research to identify novel causes. A recent Nature study reported that imidazole propionate made by gut bacteria contributes to atherosclerosis development, supporting its potential role as a biomarker of subclinical disease.
by GMFH Editing Team
In this video interview, Dr. Mireia Vallès-Colomer explains how our microbiome is formed, shared, and transmitted throughout life — and why understanding these microbial connections is key for human and planetary health.
by Andreu Prados
Although the underlying cause of irritable bowel syndrome is unclear, many people with IBS believe they are sensitive to gluten or wheat. A new study finds gluten and wheat are safe for many people with IBS, and the culprit might be something else.
by GMFH Editing Team
Across social media, #fibermaxxing is inspiring people to boost their daily fiber intake. While enthusiasm for healthier eating is positive, this trend also invites an important question: what does science really say about fiber, microbiota, and health?
by Karen Madsen
Previous clinical studies have shown a promising role of fecal microbiota transplantation to induce remission in ulcerative colitis and maintain steroid-induced Crohn’s disease remission. A new double-blind, placebo-controlled trial found fecal microbiota transplantation is not effective at inducing clinical or endoscopic remission in adults with Crohn’s disease.
Vaccines have been protecting us from infectious diseases for over 200 years. Interestingly, recent research suggests unexpected players may be at work behind the scenes: the trillions of microbes that comprise our gut microbiota. Researchers continue to explore how gut microbiota influence immunity, why vaccine responses vary, and whether diet and prebiotics can tip the balance in our favour.
